Announced Tue, 16 Jun · 17:26 IST
Dr. Anwar Daud acquires 80,000 shares via inter-se promoter transfer
ZIMLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+2.3%1-day move
₹111.50
prior close
₹112.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-3.5-3.5-3.1-1.8+2.3+7.3+12.5+8.5+14.7+11.2+4.0+12.5——
Up moveDown movePending
AI summary
Dr. Anwar Daud acquired 80,000 equity shares (0.15%) of Zim Laboratories from fellow promoter Mr. Zulfiquar Kamal at ₹107.50/share on 11 June 2026. Dr. Daud's stake rose from 24.90% to 25.05%; Kamal's fell from 2.23% to 2.08%. The transaction qualifies for exemption under Regulation 10(1)(a)(ii) as an inter-se transfer among promoters, with no open offer triggered.
Likely market impact
Minor internal promoter reshuffle; total promoter holding unchanged. Negligible impact on share price or retail investors.